HOMB NYSE Week ended 25 Sep 2026

Weekly Investor Report

Home BancShares Inc · Financial Services · Banks - Regional

Open interactive chart View report data
Latest close 29.19 USD
-2.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.3% above the Trend Line and sits at 61.3% of its 52-week range. The latest completed week returned -2.0%, after a -1.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is mixed with 6/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 17d.

Setup score 48 out of 100
Latest Close 29.19 USD 25 Sep 2026
1W Return -2.0% latest completed week
4W Return -1.5% short-term follow-through
12W Return 1.8% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 10-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.0% Latest completed week; four-week move -1.5%. Indicator stack 50/43 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 6/100 conviction; expected move 0.0%. News sentiment 56/100 26 relevant articles in the latest sentiment read. Event risk 17d Next report is scheduled for 14 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.3% above the Trend Line and sits at 61.3% of its 52-week range. The latest completed week returned -2.0%, after a -1.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep 25 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8412-week average 0.65

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.84Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.5% over four weeks, 1.8% over 12 weeks, and 3.8% over one year. The current trend has remained active for 10 consecutive weeks.

Performance by holding period

1W-2.0%
4W-1.5%
12W1.8%
26W11.3%
52W3.8%
Active trend streak10 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.03Latest activity-pressure read.
Pressure change-96.9%Four-week change in activity pressure.
Leadership-4.75Latest relative-leadership reading.
RS change-23.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 18 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength84/100Blend of value, momentum, and quality. Underlying universe rank 17; rank 1 is best.
Value81/100Relative valuation strength. Underlying universe rank 20; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum27/100Medium-term price momentum. Underlying universe rank 74; rank 1 is best.
Growth9/100Revenue and earnings growth. Underlying universe rank 92; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework88/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.4x
Price divided by trailing earnings.
Price / sales
4.3x
Market value relative to trailing revenue.
EV / EBITDA
10.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
78.5%
Gross profit retained from each unit of revenue.
Operating margin
43.6%
Operating profit retained from revenue.
Free-cash-flow margin
30.8%
Free cash flow generated from revenue.
Return on invested capital
9.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.8%
Latest one-year revenue growth.
EPS growth
10.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
20.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.9%
Cash dividends relative to market value.
Buyback yield
1.3%
Net share repurchases relative to market value.
Shareholder yield
4.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

HOMB shows mixed options pressure with a 6/100 conviction score, put-call volume ratio of n/a, expected move of n/a, and Sharemaestro trend signal active.

Conviction6/100
Expected move%
Put/call volume
Pressure9
Speculation0
Volatility20
Trend agreement0
Open options detail
Insider activity3 / 9

3 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 26 relevant articles.

13 positive · 13 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings17dNext report is scheduled for 14 Oct 2026; event risk rises as the date approaches.
Options expected move%Nearest-chain priced movement where available.
52-week drawdown-7.5%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+7.4%Week of 17 Jul.
Worst week-3.9%Week of 17 Apr.
Latest week-2.0%Week of 25 Sep.

Shape of recent returns

Strong gains3
Modest gains11
Flat weeks0
Modest losses12
Sharp losses0
Recent vol2.7%13-week weekly-return volatility.
Base vol2.7%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.1% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape48/100

Trend, activity pressure, participation, and risk combine to a 48/100 tape read.

 Indicator analysis66/100

Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 4/12.

Activity pressure 0.84; 3 reversal markers Factors71/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 24; Small Cap Core rank 33 SVQF88/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 125.0 of 1061 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options23/100

No clear directional balance. Options do not give a clear directional confirmation of the stock trend.

2026-09-25 · Use with limits · Priced move Unavailable Sentiment56/100

Weighted news tone is neutral across 26 relevant articles.

Home BancShares (HOMB) Gets A Zacks Lift, Is The Stock Already Fully Valued? Insiders3 / 9

3 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings17d

Next report is scheduled for 14 Oct 2026; event risk rises as the date approaches.

 Research flow2 items

0 recent research articles and 2 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
25 Sep 202629.19 USD-2.0%28.25 USD26.15 USD0.03-4.757.2MOn
18 Sep 202629.79 USD-0.6%28.18 USD26.09 USD0.22-1.8010.3MOn
11 Sep 202629.97 USD-0.6%28.16 USD26.02 USD0.41-1.515.3MOn
4 Sep 202630.15 USD1.8%28.13 USD25.96 USD0.67-1.947.0MOn
28 Aug 202629.62 USD-2.1%28.13 USD25.90 USD0.80-3.856.2MOn
21 Aug 202630.27 USD-3.6%28.09 USD25.84 USD1.04-1.606.7MOn
14 Aug 202631.39 USD2.6%28.01 USD25.78 USD1.180.346.2MOn
7 Aug 202630.58 USD-0.8%27.92 USD25.71 USD1.29-2.226.6MOn
31 Jul 202630.84 USD0.3%27.83 USD25.66 USD1.271.928.3MOn
24 Jul 202630.75 USD0.5%27.72 USD25.60 USD1.222.639.9MOn
17 Jul 202630.61 USD7.4%27.63 USD25.55 USD1.261.4412.8MOff
10 Jul 202628.51 USD-0.6%27.54 USD25.49 USD1.14-7.268.6MOff
3 Jul 202628.68 USD-2.1%27.53 USD25.44 USD1.19-5.808.8MOff
26 Jun 202629.30 USD6.0%27.51 USD25.39 USD1.00-2.0613.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context